This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Aglossia (Congenital Absence of the Tongue)무설증

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q38.3 (Aglossia) | Special Copayment Reduction: V241
B. Synonyms—
C. Adult onsetPossibility of first presentation in adulthood: very low — aglossia is a congenital malformation in which all or most of the tongue is absent from birth. It is identified immediately in the neonatal period by feeding difficulties and abnormal oral appearance. There are no cases first diagnosed in adulthood.
1. HistoryHistory of clinical descriptions of aglossia; medieval medical records; modern case reports; recognition in the field of craniomaxillofacial malformations.
2. CausesAbnormal embryonic tongue development; developmental defect of the first and second pharyngeal (branchial) arches; mostly sporadic.
3. GeneticsMostly sporadic; possible association with variants in oral development genes such as SOX2, PAX9, and MSX1; associated with syndromes (Hanhart, Möbius).
4. General epidemiologyVery rare; about 100 cases reported worldwide; sex and ethnic differences unclear; other congenital malformations commonly associated.
5. PathophysiologyDevelopmental arrest or regression of the tongue bud derived from the first and second pharyngeal arches; failure of formation of tongue muscle and mucosa.
6. SymptomsInability to feed, dysphagia, speech impairment (inability to articulate), dry mouth, mandibular hypoplasia.
7. SignsAbsence of the tongue in the oral cavity (complete or partial), mandibular hypoplasia, malocclusion, oral mucosal abnormalities, delayed speech development.
8. ScreeningPrenatal ultrasound (fetal oral assessment); neonatal oral physical examination; immediate oral assessment when feeding difficulties occur.
9. DiagnosisOral physical examination, maxillofacial CT/MRI, swallowing function tests, speech evaluation, genetic testing (evaluation for associated syndromes).
10. TreatmentFeeding support (nasogastric tube, gastrostomy); speech therapy; maxillofacial rehabilitation; tongue reconstruction (flap transfer); multidisciplinary team approach.
11. PrognosisSurvival possible, but permanent speech and swallowing impairment; adaptation possible in partial aglossia; quality of life improved with multidisciplinary rehabilitation.
12. PreventionPrimary prevention difficult (sporadic); prenatal ultrasound screening; early multidisciplinary intervention.
13. ReferencesVenegas-Ahedo L et al., Int J Oral Maxillofac Surg 2013; Figueiredo JAP et al., 2014 and 8 others

1. History

Aglossia (ICD-10 Q38.3) is a very rare congenital malformation in which the tongue is congenitally completely or almost completely absent. Clinical descriptions of this condition date back to medieval medical literature. European medical literature of the 15th–16th centuries contains descriptions of children born 'tongue-less,' some of which may have been confused with acquired cases in which the tongue was lost through surgery or other causes. The first clear descriptions of congenital aglossia can be found in the anatomical and medical literature of the 17th–18th centuries.

Clinical reports of aglossia in the modern sense appear from the late 19th century. These reports focused mainly on the dramatic abnormality of oral appearance and the inability to speak. As understanding of craniomaxillofacial malformations advanced in the early 20th century, aglossia began to be classified as one of the congenital malformations associated with abnormal pharyngeal (branchial) arch development. In the 1930s–1940s, Hanhart syndrome (hypoglossia-hypodactyly syndrome), in which aglossia is accompanied by limb defects, was described.

In the late 20th century, advances in imaging technology made accurate anatomical description of aglossia possible, and abnormalities of the oral soft tissues and bony structures could be evaluated in detail with CT and MRI. From the 1970s–1980s onward, with advances in maxillofacial reconstructive surgery and microvascular surgical techniques, tongue reconstruction began to be attempted, but functional tongue reconstruction remains very difficult and limited. Advances in speech therapy led to the development of adaptive methods that train patients to achieve some communication even without a tongue, and the introduction of augmentative and alternative communication (AAC) devices has contributed to improving the communication abilities of patients with aglossia.

Cases of aglossia have also been reported rarely in Korea, and they are managed with a multidisciplinary approach involving pediatric craniomaxillofacial surgery, pediatrics, otorhinolaryngology, and speech therapy. Patient support is available through registration for the rare disease Special Copayment Reduction V241. Aglossia is an ultra-rare disease with only a few hundred cases reported in the literature worldwide; large-scale epidemiological studies or randomized controlled trials are not possible, so most treatment evidence remains at the level of case reports.

Recently, maxillofacial reconstruction using 3D printing technology and virtual surgical planning, and advances in free flap transfer for tongue reconstruction, are increasing the possibilities for surgical treatment of patients with aglossia. In addition, advances in augmentative and alternative communication devices and artificial intelligence-based speech assistance technologies are contributing to improving patients' social participation and quality of life.

2. Causes

The cause of aglossia lies in complete or near-complete failure of tongue formation during embryonic oral development. Normal tongue development takes place between weeks 4 and 8 of gestation: the anterior and posterior parts of the tongue are formed by fusion and growth of the two lateral lingual swellings and the median swelling (tuberculum impar) derived from the first pharyngeal arch (first branchial arch), and the hypopharyngeal eminence (copula) derived from the second, third, and fourth pharyngeal arches.

Aglossia is understood to result from failure of initial development of the tongue bud in this process, arrest of growth after initial development, or involution of already formed structures. Complete aglossia is the absence of the entire tongue, and partial aglossia (or microglossia) is when the tongue is only partially formed. From an embryological standpoint, aglossia is presumed to arise from abnormal migration or differentiation of neural crest cells involved in tongue formation, or from abnormalities in signaling pathways regulating pharyngeal arch development.

Aglossia mostly occurs sporadically, without a clear genetic cause. In some cases, however, it is accompanied by other congenital malformations, suggesting a complex developmental abnormality. The best-known associated syndrome is Hanhart syndrome (hypoglossia-hypodactyly syndrome), in which underdevelopment of the tongue (aglossia or hypoglossia) is accompanied by congenital absence of fingers and toes (amelia, ectrodactyly). Möbius syndrome may also be accompanied by tongue abnormalities (hypoglossia), together with palsy of cranial nerves VI and VII. It has been hypothesized that vascular disorders during pregnancy, fetal vascular accidents, or environmental factors (specific factors not established) may be involved.

Reported associated malformations include hypoplasia of the mandible, maxillofacial asymmetry, palatal abnormalities (cleft palate, high-arched palate), dental abnormalities (tooth agenesis, malposition), and limb malformations (limb defects, polydactyly, syndactyly). Because mandibular development is normally promoted by mechanical stimulation from the tongue, mandibular hypoplasia in aglossia also arises partly as a secondary effect.

3. Genetics

The genetic basis of aglossia has not yet been fully elucidated. Most cases occur sporadically, and no clear mode of inheritance due to a single-gene abnormality has been established. However, several genes involved in tongue and oral development may have potential associations.

Genes that play important roles in tongue development that have been studied include the following. SOX2 is involved in the development of the oral ectoderm and sensory organs, and SOX2 variants are associated with complex malformations such as anophthalmia and oral abnormalities. MSX1 and PAX9 are essential for dental and maxillofacial development, and their variants are associated with tooth agenesis. Genes directly essential for tongue development include the nuclear receptors HOXA2, HOXD4, DLX1/2/5/6 (regulating pharyngeal arch development), and EDN1 (endothelin-1, regulating differentiation of pharyngeal arch neural crest cells), and animal studies have confirmed that loss of these genes causes abnormal tongue development.

The genetic cause of Hanhart syndrome has not yet been fully elucidated. Gene variants related to abnormal vascular formation have been reported in some cases, but no specific single causative gene has been established. Most cases of Hanhart syndrome are sporadic. In Möbius syndrome, variants in genes such as PLXNA1 and REV3L have been reported in some cases, and there is a hypothesis that abnormalities of chromosomes 6 and 13 are associated. Variants in TFAP2A, TWIST1, and others, which are central to neural crest cell differentiation throughout craniofacial development, are also associated with a wide range of craniomaxillofacial malformations.

Reports of familial aglossia are extremely rare, so the likelihood of single-gene inheritance is low. Future studies are needed to search for causative variants in patients with sporadic aglossia using next-generation sequencing (NGS)-based whole-exome or whole-genome analysis. Routine genetic testing of patients with aglossia is currently not recommended in clinical practice, but when associated malformations are present, chromosome analysis and gene panel testing are useful for identifying a syndromic cause.

4. General epidemiology

Aglossia is an extremely rare congenital malformation worldwide, and its exact prevalence has not been established. The total number of aglossia cases reported in the medical literature to date is estimated at about 100 or fewer; among these, complete aglossia (absence of the entire tongue) is even rarer, and partial aglossia (hypoglossia, microglossia) is reported more often. The incidence is estimated at less than approximately 1/100,000 births, but there are no official epidemiological data to support this.

Regarding sex distribution, the number of reported cases is too small to determine a clear sex difference. Some reports indicate a slight male predominance, but without statistical significance. The ethnic distribution is also unclear owing to literature reporting bias, but it is understood to occur in all ethnic groups worldwide.

Aglossia is more commonly accompanied by other congenital malformations than it occurs in isolation. The most commonly associated malformations are mandibular hypoplasia, dental abnormalities, palatal abnormalities, and limb malformations (as part of Hanhart syndrome). When associated malformations are present, social functional impairment and medical needs are greater. The proportion of cases occurring as isolated aglossia or as part of Hanhart syndrome is reported variably in the literature.

In Korea, the exact number of registered patients with aglossia among malformations classified under the rare disease Special Copayment Reduction V241 has not been published, but considering the worldwide prevalence, the number of patients in Korea is estimated to be very small (a few dozen or fewer). Diagnosis and management of patients with aglossia are carried out cooperatively by a multidisciplinary team including pediatrics, craniomaxillofacial surgery, otorhinolaryngology, speech therapy, and rehabilitation medicine. Although very few, patients with aglossia have also been reported in Korea, and cases have been described in which adaptive communication skills were developed through specialized speech therapy and rehabilitation.

5. Pathophysiology

The pathogenesis of aglossia is that normal embryonic development of the tongue stops at an early stage, or development that has already begun regresses. The tongue is formed from around the 4th week of embryonic life by fusion and growth of several primordia derived from the first, second, third, and fourth pharyngeal arches. Specifically, the anterior 2/3 of the tongue is formed by fusion of the two lateral lingual swellings and one median swelling (tuberculum impar) of the first pharyngeal arch, and the posterior 1/3 of the tongue develops from the hypopharyngeal eminence (copula, hypobranchial eminence) derived from the second, third, and fourth pharyngeal arches. The primordium of the hyoid bone also develops during this process.

In aglossia, these primordia are presumed to develop insufficiently or to regress abnormally after developing. Given that the critical period is weeks 4–8 of gestation, abnormal embryonic development during this period acts as the decisive factor in aglossia. Abnormalities of the Wnt, FGF, BMP, and Hedgehog signaling pathways that regulate pharyngeal arch development may be involved, and the leading hypothesis is that defects in the migration or differentiation of neural crest cells lead to developmental failure of pharyngeal arch components. It has also been hypothesized that fetal vascular accidents (interruption or reduction of the tongue's blood supply) may damage already formed tongue primordia.

In aglossia, the absence of the tongue causes secondary maxillofacial developmental abnormalities. Normally, as the tongue grows, it exerts mechanical stimulation on the mandible, promoting its anterior and vertical growth. Without the tongue, this stimulation is absent, resulting in mandibular hypoplasia and worsening malocclusion and facial asymmetry. In addition, because the tongue is essential for swallowing and feeding in normal infants, oral feeding is impossible or extremely difficult in neonates with aglossia. In terms of speech development, the tongue is essential for articulating consonants and vowels in almost all languages, including Korean, so normal speech development is impossible in aglossia, and adaptive communication methods must be developed.

6. Symptoms

The clinical symptoms of aglossia center on the complete or near-complete loss of tongue functions (feeding, swallowing, speech, oral sensation, oral cleansing) due to complete absence or severe hypoplasia of the tongue.

Neonatal feeding impairment: the most immediate problem is inability to feed. Normal neonates take in breast milk or formula through sucking movements using the tongue on the nipple or bottle teat. Without a tongue, this movement is impossible, so oral feeding is impossible or very difficult from immediately after birth. Neonates with aglossia require nutritional support through a nasogastric tube or gastrostomy tube.

Dysphagia: the tongue is essential for the oral phase of swallowing, which pushes food in the mouth into the pharynx. Without a tongue, oral-phase swallowing is impossible, so food pools in the mouth or voluntary swallowing does not occur. In some patients, partial swallowing becomes possible through adaptive use of the remaining oral and pharyngeal structures.

Speech impairment: the tongue is essential for articulating tongue-tip consonants (apical sounds: Korean n, d, s, r/l, etc.), dorsal sounds (Korean g, k, etc.), and vowels. When the tongue is completely absent, normal articulation is impossible. Some patients develop compensatory articulation using other oral structures (lips, teeth, soft palate) or use augmentative and alternative communication (AAC) devices. Language comprehension is unrelated to the tongue, so when cognitive development is normal, language comprehension and reading are possible.

Dry mouth and oral hygiene problems: the tongue contributes to stimulating saliva secretion, clearing food from the mouth, and self-cleansing of the oral mucosa. In aglossia, dry mouth (xerostomia), increased dental caries, and accumulation of food residue in the mouth become problems. Dental care and oral hygiene assistance are very important.

Impaired mandibular and dental development: lack of mechanical stimulation from the tongue can cause mandibular hypoplasia, lingual inclination of the mandibular incisors, anterior open bite, malocclusion, and facial asymmetry. Continuous collaboration with orthodontics is needed during the growth period.

7. Signs

Signs identified on physical examination are as follows.

Absence of the tongue in the oral cavity: when the mouth is opened, the tongue is not visible at all (complete aglossia), or only vestigial tissue is present on the floor of the mouth. In partial aglossia, a very small tongue (microglossia) is observed attached to the floor of the mouth. The frenulum is absent or abnormally positioned.

Abnormal oral structures: the floor of the mouth is flat and covered only with mucosa, without tongue tissue. The oral mucosa is dry or abnormally smooth. Teeth may be absent (anodontia, tooth agenesis), may erupt in abnormal positions, or may have abnormal shapes.

Mandibular and facial abnormalities: due to mandibular hypoplasia, micrognathia, anterior open bite, and shortening of the lower face may be observed. In some cases, facial asymmetry worsens as growth proceeds. The degree of mandibular development is accurately assessed by CT.

Speech and developmental findings: oral speech production is impossible or extremely limited; when augmentative and alternative communication is used, AAC devices or sign language are employed. Cognitive ability is unrelated to the tongue abnormality, so in isolated aglossia, intelligence and language comprehension are normal. Associated syndromes (Möbius, etc.) may be accompanied by cranial nerve palsies, intellectual disability, and the like.

Findings of associated malformations: with Hanhart syndrome, finger and toe defects (limb defects, polydactyly, etc.) are also observed. With Möbius syndrome, facial palsy (symmetric expressionless face) and abducens nerve palsy (esotropia) appear.

8. Screening

Population-wide screening for aglossia is not performed. However, early detection is possible in the following situations.

Prenatal ultrasound screening: evaluating fetal oral structures on the detailed ultrasound (anomaly scan) at 18–22 weeks of gestation can confirm whether the tongue is present. The fetal tongue can be observed on ultrasound along with mouth-opening movements, and if the tongue is not visible or is markedly small, aglossia or hypoglossia may be suspected. However, tongue assessment on fetal ultrasound can be difficult depending on fetal position, ultrasound technique, amniotic fluid volume, and so on, so prenatal diagnosis is not always possible.

Neonatal oral physical examination: inspection and palpation of the inside of the mouth during the neonatal physical examination immediately after birth can confirm whether the tongue is present. In neonates with feeding difficulties (inability to suck, regurgitation of milk), oral structural abnormalities must be evaluated immediately. If the tongue is not visible when the neonate opens the mouth, immediate oral examination and further evaluation are needed.

Situations raising clinical suspicion: when inability to feed orally, regurgitation during feeding, or absent sucking is observed in the neonatal period, oral abnormalities including tongue malformations must be considered in the differential diagnosis. In growing children with delayed speech development or complete inability to produce oral speech, evaluation for abnormal oral anatomy is needed.

9. Diagnosis

The diagnosis of aglossia is mainly clinical, confirming the absence or extreme hypoplasia of the tongue on oral physical examination. Additional tests are used for detailed anatomical evaluation, identification of associated malformations, and treatment planning.

Oral physical examination: the presence of the tongue in the mouth, the size and position of tongue tissue, the condition of the oral mucosa, the teeth and dentition, and the shape of the palate are assessed by inspection and palpation. In neonates, the structure of the floor of the mouth is checked by finger palpation.

Maxillofacial CT and MRI: CT precisely evaluates the developmental status of the mandible, maxilla, teeth, and hyoid bone and is useful for identifying residual tongue tissue or related soft tissue abnormalities. MRI is superior for evaluating soft tissue abnormalities (tongue muscles, floor of the mouth, pharyngeal soft tissue) without radiation. Both methods are essential for surgical planning.

Swallowing function tests: the videofluoroscopic swallowing study (VFSS) dynamically evaluates swallowing function in the oral and pharyngeal phases and is used to identify the risk of aspiration. Fiberoptic endoscopic evaluation of swallowing (FEES) is also used to assess swallowing function.

Speech evaluation: a speech-language pathologist assesses oral motor function, phonology, and communication ability. Cognitive and language abilities are assessed with standardized language development tests (K-WISC, receptive and expressive vocabulary tests, etc.). The need for augmentative and alternative communication (AAC) is assessed.

Genetic testing and genetic counseling: when associated malformations are present, chromosome analysis (G-banding karyotype), array comparative genomic hybridization (array CGH), or gene panel testing is performed to identify a syndromic cause. Genetic counseling provides information on recurrence risk and other associated conditions.

10. Treatment

Because complete reconstruction of the tongue is impossible with current technology, the treatment of aglossia centers on a multidisciplinary approach focused on compensating for function and improving adaptive abilities.

Nutritional support: when oral feeding is impossible in the neonatal period, immediate nasogastric (NG) tube feeding is needed. In the long term, gastrostomy (PEG tube) is adopted as a stable method of nutritional support. When swallowing function is partially present, some oral intake may be allowed with swallowing therapy and adjustment of food viscosity.

Speech-Language Therapy: the speech-language pathologist provides compensatory articulation training using oral structures available without a tongue (lips, teeth, soft palate, pharynx). When oral speech is extremely limited, augmentative and alternative communication (AAC) — picture cards, sign language, electronic AAC devices, speech synthesizers — is introduced. Language development support to improve language comprehension and reading and writing skills is also important.

Maxillofacial reconstruction (Orthopedic and Surgical Management): when mandibular hypoplasia is present, orthodontic appliances, distraction osteogenesis, or mandibular reconstruction are performed in collaboration between orthodontics and maxillofacial surgery. Orthodontic treatment and dental prostheses are needed for dental abnormalities. Tongue reconstruction is being attempted by creating a tongue shape with flap transfer (forearm free flap, anterolateral thigh free flap, etc.), but complete reconstruction of a functional tongue (sensory, motor) is currently impossible, and the goal is aesthetic and partial functional improvement.

Oral hygiene management: to prevent dental caries due to the absence of the tongue's self-cleansing function, electric toothbrushes, oral irrigators, fluoride toothpaste, and regular dental checkups are essential. Artificial saliva and hydration are needed to relieve dry mouth.

Psychological and social support: psychological counseling and peer group support are important for addressing psychological difficulties due to appearance and communication limitations. Family education and support are also essential for the patient's adjustment.

11. Prognosis

The prognosis of aglossia varies greatly depending on the extent of the tongue defect, the presence and severity of associated malformations, and the timing of initiation of a multidisciplinary rehabilitation approach.

Survival and physical growth: with appropriate nutritional support (gastrostomy, etc.), survival is possible and physical growth can also be maintained. In the absence of associated malformations, the vital prognosis is good. Aspiration pneumonia is an important complication in patients with impaired swallowing, and early aspiration prevention and swallowing management affect prognosis.

Speech and communication: in complete aglossia, normal oral speech development is impossible. However, cases have been reported of developing effective communication skills with appropriate speech therapy and the introduction of AAC. When cognitive ability is normal, social communication is possible through reading, writing, sign language, and AAC devices. In partial aglossia, some oral speech production is possible in some cases with compensatory articulation training.

Quality of life: permanent speech and swallowing impairments seriously affect social participation and quality of life. However, with modern AAC technology and multidisciplinary support, social integration and participation in education are becoming possible. Psychological support and building social support systems are very important for long-term quality of life.

Follow-up: maxillofacial development, dentition, swallowing function, speech and communication abilities, and nutritional status are assessed regularly, and the treatment plan is revised. Continuous support from a multidisciplinary team is recommended into adulthood.

12. Prevention

Primary prevention of aglossia is practically difficult because it mostly occurs sporadically. General fetal malformation prevention strategies during pregnancy (folic acid intake, rubella prevention, avoidance of teratogens) may lower the risk of congenital malformations overall, but no specific effect on aglossia has been established.

Prenatal diagnosis (secondary prevention): evaluating fetal oral structures on the detailed ultrasound at 18–22 weeks of gestation can raise prenatal suspicion of aglossia. When a prenatal diagnosis is made, formation of a multidisciplinary team before delivery, preparation for immediate neonatal nutritional support, and parental education and psychological support can be planned in advance. When associated malformations are suspected, prenatal genetic counseling and additional tests (amniocentesis, chorionic villus sampling) are performed.

Early intervention (tertiary prevention): immediate multidisciplinary evaluation and initiation of nutritional support after birth, early start of speech therapy, and monitoring of maxillofacial development help minimize complications (aspiration pneumonia, severe mandibular hypoplasia, delayed speech development). Parental education and linkage to support groups are important for the family's psychological adjustment.

13. References

  1. Venegas-Ahedo L, Jimenez-Castillo G, Delgado-Hernandez A. Aglossia: a very rare congenital anomaly. Int J Oral Maxillofac Surg. 2013;42(8):1010-1012. PMID: 23591261.
  2. Figueiredo JAP, Figueiredo NF, Figueiredo AJPF. Aglossia: case report and review of the literature. J Pediatr Surg. 2014;49(4):622-625. PMID: 24726123.
  3. Bhatt YC, Sankalecha M, Bhatt AB, et al. Aglossia with multiple associated anomalies. Indian J Plast Surg. 2012;45(2):368-371. PMID: 23162238.
  4. Temtamy SA, McKusick VA. The genetics of hand malformations. Birth Defects Orig Artic Ser. 1978;14(3):i-619. PMID: 215242.
  5. de Graaf-Peters VB, Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when? Early Hum Dev. 2006;82(4):257-266. PMID: 16360292.
  6. Hall BD. Aglossia-adactylia. Birth Defects Orig Artic Ser. 1971;7(7):233-236. PMID: 5173090.
  7. Wiersma R. Hanhart's syndrome: hypoglossia-hypodactylia. Pediatr Surg Int. 2003;19(6):432-434. PMID: 12748882.
  8. Gorski SM, Adams KJ, Birch PH, et al. Linkage analysis of X-linked cleft palate and ankyloglossia in Manitoba Mennonite and British Columbia native kindreds. Hum Genet. 1994;94(2):141-148. PMID: 8045517.
  9. Light J. Toward a definition of communicative competence for individuals using augmentative and alternative communication systems. Augment Altern Commun. 1989;5(2):137-144.
  10. Kaban LB, Moses MH, Mulliken JB. Surgical correction of hemifacial microsomia in the growing child. Plast Reconstr Surg. 1988;82(1):9-19. PMID: 3380303.